NS

Nileshkumar S Makadia

Active Director Whole-Time Director DIN 00462419
DIN 00462419 First appointment Nov 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Nov 2004
Shareholding value •••• Premium profile

About Nileshkumar S Makadia

Data last updated:

Nileshkumar S Makadia is a Whole-Time Director at Adroit Pharmachem Private Limited (since 2015), Director at Adroit Naturals Private Limited (since 2024) and Director at Jagdish Precision Cast Private Limited (since 2004), and holds 2 more current directorships. The companies operate in Pharma, Agriculture and Manufacturing. The 5 current companies with reported revenue have a combined latest revenue of ₹147 Cr; the largest is Adroit Pharmachem Private Limited at ₹83.57 Cr (FY 2025).

DIN 00462419
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 05 Nov 2004
Oldest Company Age 21 yrs
Largest company Adroit Pharmachem Private Limited · ₹83.57 Cr (FY 2025)
Combined revenue ₹147 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adroit Pharmachem Private Limited U24100GJ2013PTC073351
Whole-Time Director21 Mar 20152013₹83.57 Cr (FY 2025)Active
Adroit Naturals Private Limited U24299GJ2022PTC133110
Director01 Aug 20242022₹51.13 Cr (FY 2025)Active
Director05 Nov 20042004₹12.13 Cr (FY 2024)Active
Sthapana Residency Private Limited U45200GJ2014PTC081512
Director11 Dec 20142014₹35.5 Lakh (FY 2026)Active
Rudraksh Heritage Owners Association U85300GJ2021NPL120055
Director06 Feb 20212021₹24.8 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Adroit Pharmachem Private Limited
Jagdish Precision Cast Private Limited
Sthapana Residency Private Limited
Rudraksh Heritage Owners Association
Premium access

Shareholding and investment profile for Nileshkumar S Makadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nileshkumar S Makadia

Nileshkumar S Makadia currently holds 5 directorships: Adroit Pharmachem Private Limited (Whole-Time Director, since 21 Mar 2015, revenue ₹83.57 Cr (FY 2025)); Adroit Naturals Private Limited (Director, since 01 Aug 2024, revenue ₹51.13 Cr (FY 2025)); Jagdish Precision Cast Private Limited (Director, since 05 Nov 2004, revenue ₹12.13 Cr (FY 2024)); Sthapana Residency Private Limited (Director, since 11 Dec 2014, revenue ₹35.5 Lakh (FY 2026)); Rudraksh Heritage Owners Association (Director, since 06 Feb 2021, revenue ₹24.8 Lakh (FY 2024)).

Nileshkumar S Makadia was first appointed on 05 Nov 2004 as Director at Jagdish Precision Cast Private Limited. The most recent appointment on record is 01 Aug 2024 at Adroit Naturals Private Limited.

The 5 current companies of Nileshkumar S Makadia that report revenue have a combined latest revenue of ₹147 Cr: Adroit Pharmachem Private Limited ₹83.57 Cr (FY 2025); Adroit Naturals Private Limited ₹51.13 Cr (FY 2025); Jagdish Precision Cast Private Limited ₹12.13 Cr (FY 2024); Sthapana Residency Private Limited ₹35.5 Lakh (FY 2026); Rudraksh Heritage Owners Association ₹24.8 Lakh (FY 2024).

The current boards of Nileshkumar S Makadia's companies include Alpeshkumar Ratilal Sinojia (Adroit Pharmachem Private Limited), Rajulkumar Shamjibhai Makadia (Adroit Pharmachem Private Limited), Chetankumar Ratilal Sinojia (Adroit Naturals Private Limited), Dev Rajulkumar Makadia (Adroit Naturals Private Limited), Jeetkumar Nileshkumar Makadia (Adroit Naturals Private Limited), Himanshu Laljibhai Patel (Jagdish Precision Cast Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available